Nemokumas ES - Company finances
|
EUR
|
2022
From: 2022-01-24
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 9,255 | 8,190 | 3,875 | 10,305 |
| Profit before tax | 215 | -3,169 | -4,929 | -1,309 |
| Net profit | 204 | -3,169 | -4,929 | -1,309 |
| Equity | 204 | -2,964 | -7,893 | -9,202 |
| Liabilities | 951 | 3,232 | 8,693 | 9,483 |
| Non-current assets | 0 | 0 | 264 | 264 |
| Current assets | 1,155 | 268 | 536 | 17 |
| Total assets | 1,155 | 268 | 800 | 281 |
|
Taxes paid
|
||||
| STI taxes | - | 228 | 234 | 309 |
|
Financial indicators
|
||||
| Revenue change y/y | - | -11.5% | -52.7% | +165.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 17.7% | -1182.5% | -616.1% | -465.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.2% | -38.7% | -127.2% | -12.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.3% | -38.7% | -127.2% | -12.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.7 | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,255 | 8,190 | 3,875 | 10,305 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nemokumas ES - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-12-04 | 2025-12-07 | 53.22 |
| 2025-11-28 | 2025-12-03 | 71.33 |
| 2025-11-18 | 2025-11-27 | 72.42 |
| 2025-10-16 | 2025-11-05 | 72.42 |
| 2025-09-16 | 2025-10-02 | 72.42 |
| 2025-08-31 | 2025-09-03 | 72.43 |
| 2025-08-19 | 2025-08-29 | 72.43 |
| 2025-07-16 | 2025-08-11 | 72.44 |
| 2025-07-01 | 2025-07-08 | 72.45 |
| 2025-06-12 | 2025-06-15 | 91.39 |
| 2025-06-11 | 2025-06-11 | 217.35 |
| 2025-06-08 | 2025-06-09 | 217.35 |
| 2025-06-03 | 2025-06-04 | 217.35 |
| 2025-05-16 | 2025-06-02 | 144.90 |
| 2025-05-12 | 2025-05-15 | 18.94 |
| 2025-05-04 | 2025-05-11 | 32.76 |
| 2025-03-17 | 2025-03-17 | 120.06 |
| 2025-03-14 | 2025-03-16 | 246.02 |
| 2025-03-04 | 2025-03-13 | 290.76 |
| 2025-03-03 | 2025-03-03 | 218.31 |
| 2025-03-01 | 2025-03-02 | 290.76 |
| 2025-02-18 | 2025-02-28 | 218.31 |
| 2025-02-12 | 2025-02-17 | 92.35 |
| 2025-02-11 | 2025-02-11 | 218.32 |
| 2025-02-10 | 2025-02-10 | 145.87 |
| 2025-02-01 | 2025-02-09 | 218.32 |
| 2025-01-16 | 2025-01-31 | 145.87 |
| 2025-01-13 | 2025-01-15 | 33.74 |
| 2025-01-02 | 2025-01-12 | 145.87 |
| 2024-12-22 | 2024-12-31 | 81.37 |
| 2024-12-17 | 2024-12-20 | 81.37 |
| 2024-12-03 | 2024-12-15 | 81.37 |
| 2024-11-18 | 2024-12-02 | 16.87 |
| 2024-11-04 | 2024-11-06 | 129.00 |
| 2024-10-16 | 2024-11-03 | 64.50 |
| 2024-09-10 | 2024-09-10 | 274.87 |
| 2024-09-03 | 2024-09-09 | 387.00 |
| 2024-08-19 | 2024-09-02 | 322.50 |
| 2024-08-05 | 2024-08-18 | 210.37 |
| 2024-08-01 | 2024-08-04 | 322.50 |
| 2024-07-16 | 2024-07-31 | 258.00 |
| 2024-07-09 | 2024-07-15 | 145.87 |
| 2024-07-02 | 2024-07-08 | 258.00 |
| 2024-06-03 | 2024-07-01 | 193.50 |
| 2024-05-16 | 2024-06-02 | 129.00 |
| 2024-05-10 | 2024-05-15 | 16.87 |
| 2024-05-02 | 2024-05-09 | 129.00 |
| 2024-04-16 | 2024-05-01 | 64.50 |
| 2024-04-03 | 2024-04-10 | 64.50 |
| 2024-01-16 | 2024-01-17 | 21.45 |
| 2022-10-28 | 2022-11-16 | 0.01 |
| 2022-08-23 | 2022-08-28 | 1.46 |
Nemokumas ES - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-05 | 2026-07-07 | 13.1 |
| 2026-02-21 | 2026-02-21 | 1.0 |
| 2025-07-05 | 2025-07-20 | 11.45 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nemokumas ES, MB (code 305990235) is a Small partnership engaged in Legal activities. In 2025, revenue increased to €10.3K, up from €3.9K in 2024 and €8.2K in 2023, showing a rebound after the prior year decline. Despite higher turnover, the company remained loss-making: net loss narrowed to €1.3K in 2025 from €4.9K in 2024 and €3.2K in 2023, and the profit margin improved to -12.7% from -127.2% in 2024 and -38.7% in 2023. The balance sheet remained very small. Total assets stood at €281 in 2025, compared with €800 in 2024 and €268 in 2023. Equity stayed negative and fell further to -€9.2K, while liabilities rose to €9.5K. Short-term assets were only €17 at year-end 2025, with long-term assets at €264. Revenue per employee was €10.3K and profit per employee was -€1.3K. Several ratio indicators are heavily influenced by the very small and negative equity base, so they should be interpreted cautiously.